135 related articles for article (PubMed ID: 32966903)
1. Structure based drug discovery and in vitro activity testing for DNA gyrase inhibitors of Salmonella enterica serovar Typhi.
Sharma P; Kumar M; Dahiya S; Sood S; Das BK; Kaur P; Kapil A
Bioorg Chem; 2020 Nov; 104():104244. PubMed ID: 32966903
[TBL] [Abstract][Full Text] [Related]
2. Structure based in silico analysis of quinolone resistance in clinical isolates of Salmonella Typhi from India.
Kumar M; Dahiya S; Sharma P; Sharma S; Singh TP; Kapil A; Kaur P
PLoS One; 2015; 10(5):e0126560. PubMed ID: 25962113
[TBL] [Abstract][Full Text] [Related]
3. Discovery of novel multi-substituted benzo-indole pyrazole schiff base derivatives with antibacterial activity targeting DNA gyrase.
Liu H; Chu ZW; Xia DG; Cao HQ; Lv XH
Bioorg Chem; 2020 Jun; 99():103807. PubMed ID: 32272364
[TBL] [Abstract][Full Text] [Related]
4. Detection of mutations in the gyrA gene in fluoroquinolone resistance Salmonella enterica serotypes typhi and paratyphi A isolated from the Infectious Diseases Hospital, Kuwait.
Dimitrov T; Dashti AA; Albaksami O; Jadaon MM
J Clin Pathol; 2010 Jan; 63(1):83-7. PubMed ID: 19889623
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial susceptibility pattern and sequence analysis of DNA gyrase and DNA topoisomerase IV in Salmonella enterica serovars Typhi and Paratyphi A isolates with decreased susceptibility to ciprofloxacin.
Misra R; Thakare R; Amrin N; Prasad KN; Chopra S; Dhole TN
Trans R Soc Trop Med Hyg; 2016 Aug; 110(8):472-9. PubMed ID: 27618918
[TBL] [Abstract][Full Text] [Related]
6. Discovery of New Schiff Bases Tethered Pyrazole Moiety: Design, Synthesis, Biological Evaluation, and Molecular Docking Study as Dual Targeting DHFR/DNA Gyrase Inhibitors with Immunomodulatory Activity.
Hassan AS; Askar AA; Naglah AM; Almehizia AA; Ragab A
Molecules; 2020 Jun; 25(11):. PubMed ID: 32498469
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India.
Gaind R; Paglietti B; Murgia M; Dawar R; Uzzau S; Cappuccinelli P; Deb M; Aggarwal P; Rubino S
J Antimicrob Chemother; 2006 Dec; 58(6):1139-44. PubMed ID: 17071955
[TBL] [Abstract][Full Text] [Related]
8. Identification of chebulinic acid as potent natural inhibitor of M. tuberculosis DNA gyrase and molecular insights into its binding mode of action.
Patel K; Tyagi C; Goyal S; Jamal S; Wahi D; Jain R; Bharadvaja N; Grover A
Comput Biol Chem; 2015 Dec; 59 Pt A():37-47. PubMed ID: 26410242
[TBL] [Abstract][Full Text] [Related]
9. First isolation of ciprofloxacin-resistant Salmonella enterica serovar Typhi in Taiwan.
Lee CJ; Su LH; Huang YC; Chiu CH
J Microbiol Immunol Infect; 2013 Dec; 46(6):469-73. PubMed ID: 23465712
[TBL] [Abstract][Full Text] [Related]
10. Novel restriction enzyme SSiI for the detection of mutation in GyrA gene of Salmonella enterica serovar Typhi.
Agrawal P; Kapila K; Kumar S; Ghosh AN; Maurya AK
Indian J Pathol Microbiol; 2010; 53(3):509-12. PubMed ID: 20699513
[TBL] [Abstract][Full Text] [Related]
11. Increased quinolone resistance among typhoid Salmonella isolated from Egyptian patients.
Saleh FO; Ahmed HA; Khairy RM; Abdelwahab SF
J Infect Dev Ctries; 2014 May; 8(5):661-5. PubMed ID: 24820472
[TBL] [Abstract][Full Text] [Related]
12. Screening method for Salmonella enterica serovar Typhi and serovar Paratyphi A with reduced susceptibility to fluoroquinolones by PCR-restriction fragment length polymorphism.
Hirose K; Tamura K; Watanabe H
Microbiol Immunol; 2003; 47(2):161-5. PubMed ID: 12680720
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of binding of fluoroquinolones to the quinolone resistance-determining region of DNA gyrase: towards an understanding of the molecular basis of quinolone resistance.
Madurga S; Sánchez-Céspedes J; Belda I; Vila J; Giralt E
Chembiochem; 2008 Sep; 9(13):2081-6. PubMed ID: 18677735
[TBL] [Abstract][Full Text] [Related]
14. Molecular docking, discovery, synthesis, and pharmacological properties of new 6-substituted-2-(3-phenoxyphenyl)-4-phenyl quinoline derivatives; an approach to developing potent DNA gyrase inhibitors/antibacterial agents.
Alagumuthu M; Arumugam S
Bioorg Med Chem; 2017 Feb; 25(4):1448-1455. PubMed ID: 28094220
[TBL] [Abstract][Full Text] [Related]
15. The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets.
Turner AK; Nair S; Wain J
J Antimicrob Chemother; 2006 Oct; 58(4):733-40. PubMed ID: 16895934
[TBL] [Abstract][Full Text] [Related]
16. Emergence and properties of fluoroquinolone resistant Salmonella enterica serovar Typhi strains isolated from Nepal in 2002 and 2003.
Nobthai P; Serichantalergs O; Wongstitwilairoong B; Srijan A; Bodhidatta L; Malla S; Mason CJ
Southeast Asian J Trop Med Public Health; 2010 Nov; 41(6):1416-22. PubMed ID: 21329318
[TBL] [Abstract][Full Text] [Related]
17. WQ-3810 exerts high inhibitory effect on quinolone-resistant DNA gyrase of
Koide K; Kongsoi S; Nakajima C; Suzuki Y
Biosci Biotechnol Biochem; 2019 Dec; 83(12):2249-2256. PubMed ID: 31382821
[TBL] [Abstract][Full Text] [Related]
18. Emergence of Ciprofloxacin-Resistant Salmonella enterica Serovar Typhi in Italy.
García-Fernández A; Gallina S; Owczarek S; Dionisi AM; Benedetti I; Decastelli L; Luzzi I
PLoS One; 2015; 10(6):e0132065. PubMed ID: 26121266
[TBL] [Abstract][Full Text] [Related]
19. Discovery of new Gyrase β inhibitors via structure based modeling.
Al-Nadaf AH; Salah SA; Taha MO
Comput Biol Chem; 2018 Jun; 74():263-272. PubMed ID: 29679863
[TBL] [Abstract][Full Text] [Related]
20. Decreased susceptibility to fluoroquinolones and gyrA gene mutation in the Salmonella enterica serovar Typhi and Paratyphi A isolated in Katmandu, Nepal, in 2003.
Shirakawa T; Acharya B; Kinoshita S; Kumagai S; Gotoh A; Kawabata M
Diagn Microbiol Infect Dis; 2006 Apr; 54(4):299-303. PubMed ID: 16466897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
